- UpperLongevity
- Posts
- PELOTA : THE RNA GUARDIAN THAT COULD SLOW DOWN AGING
PELOTA : THE RNA GUARDIAN THAT COULD SLOW DOWN AGING
Aging is not an end, but a battlefield. Every choice, every breath becomes a weapon to extend strength, clarity, and endurance beyond human limits.
Wonder Woman
September 08, 2025
In partnership with
💪 Dear Wonderwomen and Supermen,
Did you know that RNA degradation—just like DNA or protein degradation—could accelerate aging ?
A new Korean study is shaking up our understanding of cellular aging.
Researchers have managed to extend the life of a model organism by targeting a quality control factor called PELOTA.
This novel mechanism for eliminating defective RNA opens a promising avenue against degenerative diseases and aging.
In this edition, discover how this discovery could transform anti-aging therapies. Stay tuned until the end — this is a molecular revolution you don’t want to miss.
How 433 Investors Unlocked 400X Return Potential
Institutional investors back startups to unlock outsized returns. Regular investors have to wait. But not anymore. Thanks to regulatory updates, some companies are doing things differently.
Take Revolut. In 2016, 433 regular people invested an average of $2,730. Today? They got a 400X buyout offer from the company, as Revolut’s valuation increased 89,900% in the same timeframe.
Founded by a former Zillow exec, Pacaso’s co-ownership tech reshapes the $1.3T vacation home market. They’ve earned $110M+ in gross profit to date, including 41% YoY growth in 2024 alone. They even reserved the Nasdaq ticker PCSO.
The same institutional investors behind Uber, Venmo, and eBay backed Pacaso. And you can join them. But not for long. Pacaso’s investment opportunity ends September 18.
Paid advertisement for Pacaso’s Regulation A offering. Read the offering circular at invest.pacaso.com. Reserving a ticker symbol is not a guarantee that the company will go public. Listing on the NASDAQ is subject to approvals.
/
SPOTLIGHT
In a major breakthrough for aging science, a team of South Korean researchers has identified a key mechanism linking RNA quality to longevity. Published in PNAS, the study reveals that the PELOTA protein—part of the ribosome-associated quality control system—plays a central role in eliminating defective messenger RNA. Overactivating PELOTA in C. elegans worms significantly extended their lifespan. This function, conserved in both mice and humans, could offer a new therapeutic target for neurodegenerative diseases and cellular aging.
The Details :
PELOTA, a new guardian of longevity : PELOTA is a protein tied to ribosomal quality control, essential for removing abnormal messenger RNA. Increasing its expression in C. elegans allowed researchers to observe a longer lifespan, confirming its active role in aging regulation.
A double effect: mTOR and autophagy : The study showed that PELOTA modulates two major pathways: it inhibits the mTOR pathway (linked to cell growth) and activates autophagy (cellular cleanup). This dual action is crucial to maintaining cellular balance and slowing senescence.
A cross-species discovery : PELOTA’s protective effects were observed not only in worms but also in mice and humans, highlighting the universal importance of this RNA quality control mechanism.
Muscle aging and Alzheimer’s disease : A deficiency in PELOTA accelerates muscle aging and promotes conditions like Alzheimer’s disease. This indicates a direct link between RNA quality and age-related diseases.
A promising therapeutic lever : This research proposes a new paradigm: enhancing longevity by targeting RNA stability and quality. PELOTA thus becomes a top-priority target for future anti-aging and neuroprotective therapies.
Key Takeaway :
The impact of this discovery is significant. It broadens the field of aging biology—previously focused on DNA and proteins—by emphasizing the importance of RNA. PELOTA’s ability to synchronize mTOR and autophagy pathways offers a novel and more comprehensive strategy to slow aging. This breakthrough could revolutionize treatments for age-related diseases, introducing a new class of RNA quality control-based therapies. A new horizon is opening for regenerative medicine and aging biotechnologies.
HYPE OR FACT ?
💭 Fasting for 24 hours is enough to activate autophagy
✔️ FACT, with a caveat
Autophagy—the cellular cleanup process vital for longevity—does not activate significantly after just 24 hours of fasting in humans. Research shows it often takes 36 to 72 hours of prolonged fasting to observe a notable activation of this mechanism. However, regular intermittent fasting can gradually stimulate its effects.
LONGEVITY WISDOM
Aging is not a failure; it’s the silent accumulation of micro-imbalances that the cell failed to resolve in time.
✨ Science Monday : A recent scientific discovery on longevity
🚀 Innovation Tuesday : Promising technological advancements extending life expectancy
🍏 Vitality Wednesday : Scientifically validated habits for a longer life
🧐 Myth-busting Thursday : Debunking common longevity myths
🎬 Inspiration Friday : An informative and inspiring longevity video
🧬 Don’t gamble with your future.
Join the movement of those who refuse to age passively – the rebels, the thinkers, the ones chasing a limitless life.
👉 Subscribe. Engage. Evolve
